24 March 2025
VERIFI Clinical Validation Study Results
Watch Jeff Borcherding and Norma Palma present results from Immunovia’s most recent clinical study.
Immunovia
Our presentation at Aktiespararna Life Science Day
Watch our presentation at Aktiespararna Life Science Day
Press releases
Jeff Borcherding
Chief Executive Officer
About Immunovia
Leadership
Immunovia’s executive team has blended scientific, clinical and commercial expertise to build the leading company in early detection of pancreatic cancer. They learned best practices at many of the would top life science companies and learned to move quickly and operate efficiently at high-growth early stage companies.
Jeff Borcherding
Chief Executive Officer
Jeff is a commercial leader with a proven track record of growing businesses, building high-performance teams, and developing people. A former P&G brand manager and executive at Myriad Genetics, Jeff brings deep expertise in launching and growing products in life sciences and diagnostics.
Linkedin
Norma Palma, PhD
VP, Clinical & Medical Affairs
Norma has dedicated her career to developing breakthrough oncology solutions, both in pharmaceuticals and diagnostics. A humble and eager collaborator, Norma partners with leading experts in pancreatic cancer to develop and disseminate leading-edge science.
Linkedin
Lisa Ford, PhD, HCLD
Clinical Lab Director
Lisa is a board-certified high-complexity clinical lab director who combines a brilliant scientific mind with a practical approach to leading the lab. Lisa brings a wealth of expertise in both developing new tests and operating a high-performance clinical lab.
Linkedin
Tom King, MD, PhD
Medical Director
Tom King, MD, PhD
Medical Director
A pathologist by training, Tom has a keen eye for detail and a thoughtful, disciplined approach. His expert understanding of cancer and decades of experience running clinical laboratories enable him to provide tremendous medical counsel.
Linkedin
2024
TITLE
REPORT
Presentation
WEBCAST
TYPE
2023
TITLE
REPORT
Presentation
WEBCAST
TYPE
2022
TITLE
REPORT
Presentation
WEBCAST
TYPE
2021
TITLE
REPORT
Presentation
WEBCAST
TYPE
2020
TITLE
REPORT
Presentation
WEBCAST
TYPE
2019
TITLE
REPORT
Presentation
WEBCAST
TYPE
2018
About Immunovia
Board of Directors
Immunovia has assembled a diverse and cohesive board with expertise in multiple areas to successfully guide the company through both test development and commercialization.
Peter Høngaard Andersen, MD
Chair
A prolific scientist and entrepreneur, Peter has successfully founded and built numerous life sciences companies. A physician, Peter guides the Immunovia board with decisive, science-driven leadership and a focus on the most critical initiatives.
Linkedin
Valerie Bogdan-Powers
Director
Val is a dynamic, strategic leader who has shown the ability to grow businesses at any stage from start-up to billion-dollar multinational. At Immunovia, Val contributes strategic leadership, expert commercial instincts, and deep insights into the U.S. healthcare system, especially the commercial and government payers who control reimbursement.
Linkedin
Melissa Farina
Director
A seasoned operator and brilliant financial executive, Melissa has driven success in multiple U.S. medical device companies. She provides invaluable counsel and assistance to the Immunovia team in the areas of fundraising, corporate development, financial reporting and more.
Linkedin
Michael Löfman
Director
Michael brings decades of experience as a financial analyst and portfolio manager to Immunovia. The company’s board and leadership rely on Michael for his intuitive feel for capital markets and his understanding of investor needs.
Linkedin
Martin Møller
Director
Over a twenty-year career at McKinsey, Martin provided life sciences companies with invaluable strategic counsel and guidance. As an Immunovia director, Martin contributes disciplined strategic thinking and consistently asks thought-provoking questions to drive better decisions.
Linkedin
Hans Johannsson
Director
A former executive with Thermo-Fischer, Hans combines deep expertise in diagnostics with an active, hands-on approach. At Immunovia, Hans shares advice on a variety of initiatives, including product management, commercialization, and business development.
Linkedin
©2025 Immunovia. All rights reserved